CellenGene Achieves US Patent Approval for Breakthrough CAR-T Therapy Targeting Solid Tumors
CellenGene Co., Ltd. (CEO Ahn Jae-hyung), a Korean drug development company, received approval for the US patent on "Receptor and ...
Tag: CellenGene
CellenGene Selected for National New Drug Development Project, Advances CAR-T Therapy for Ovarian Cancer
CellenGene, a biotechnology company specializing in cell gene therapy (CEO: Ahn Jae-hyun), has been selected for the 'New Drug Ecosystem ...
POPULAR POSTS
Korean startup RoamiGo, a provider of global…
by Chloe kim . 13 Nov 2024 The inaugural AsiaStartUpExpo 2024, held virtually & hosted by KoreaTechDesk in collaboration with AsiaTechDaily, was a groundbreaking event that united…
by Aditi Dave . 21 Nov 2024 Seven dynamic South Korean startups showcased their cutting-edge solutions on October 21, 2024, ahead of Japan IT Week (October 23-25).…
by Dae-jung Park . 20 Nov 2024 On October 29, 2024, the heart of Silicon Valley pulsed with innovation as the Korea Venture Business Association (KOVA) and…
by Vallabh Rao . 20 Nov 2024 Mark your calendars for November 27, 2024, as the much-anticipated KoreaTechDesk Virtual Demo Day returns! This flagship event offers Korean…
by Richard Park . 21 Nov 2024